6 studies found for:    10561185 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM
2 Recruiting Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Condition: Leukemia Lymphocytic Chronic B-Cell
Interventions: Drug: CC-292;   Drug: Rituximab
3 Recruiting Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: NPI-0052
4 Completed External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma, B-Cell
Intervention: Other: external beam radiotherapy plus 90-Y ibritumomab tiuxetan
5 Completed A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: Bortezomib and Tositumomab I-131
6 Terminated Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Condition: Diffuse Large B Cell Lymphoma
Intervention: Drug: MK2206

Indicates status has not been verified in more than two years